Market Overview:
The global clindamycin phosphate and benzoyl peroxide market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The hospital segment is expected to dominate the market in terms of revenue share during the forecast period. North America is estimated to account for the largest share of the global clindamycin phosphate and benzoyl peroxide market in 2018, followed by Europe and Asia Pacific. However, Asia Pacific is projected to register highest CAGR over the forecast period owing to increasing demand for acne treatment products in countries such as China and India.
Product Definition:
Clindamycin Phosphate and Benzoyl Peroxide is a combination of medications used to treat acne. It works by decreasing the amount of oil produced by the skin, killing acne-causing bacteria, and preventing new acne pimples from forming.
1.2%/2.5%:
1.2%/2.5% is a concentration of the active ingredient used in various medications such as Clindamycin phosphate and Benzoyl peroxide. It’s also known as 2, 5 percent benzoyl peroxide or 2, 5-DPBPPP and sold under different brand names such as Dermagraft, Epivir, Oracea etc., worldwide.
1.2%/3.75%:
1.2%/3.75% is a concentration used in clindamycin phosphate and benzoyl peroxide market to treat bacterial infections of the skin, mouth, and vagina caused by group A beta lactamase-producing bacteria such as staphylococcus aureus (golden staph), epidermis (acne), and enterobacteriaceae species (clostridium difficile).
Application Insights:
On the basis of application, the global market has been segmented into hospital and non-hospital applications. The hospital segment dominated the overall market in terms of revenue in 2017. This is attributed to rising prevalence of bacterial infections across hospitals that require clindamycin phosphate for treatment. Furthermore, increasing number of healthcare facilities and favorable government policies are further driving demand from this sector.
The non-hospital application segment is expected to witness significant growth over the forecast period owing to rising awareness about alternative medicine coupled with an increase in incidences related to Staphylococcus aureus infections across several other applications such as veterinary clinics and clinics associated with sports activities or rehabilitation centers among others which also require clindamycin phosphate for treatment purposes.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to increasing incidence of acne and psoriasis cases in U.S., coupled with growing awareness about available treatment options among patients.
Asia Pacific is expected to be one of fastest-growing regions during the forecast years on account rising disposable income levels and improving healthcare infrastructure in countries such as China and India, which are majorly driven by innovation & development initiatives for medical treatments based on natural products such as clindamycin phosphate BP OTC drug combination tablets (BP).
Growth Factors:
- Increasing incidence of acne vulgaris: Acne is a common skin disorder that affects people of all ages and races. The increasing incidence of acne is expected to drive the demand for clindamycin phosphate and benzoyl peroxide market.
- Rising awareness about the benefits of clindamycin phosphate and benzoyl peroxide: There is a growing awareness among consumers about the benefits of using clindamycin phosphate and benzoyl peroxide for treating acne vulgaris. This is likely to boost the demand for these products in the coming years.
- Growing number of product launches: The manufacturers are launching new products in order to cater to the increasing demand for clindamycin phosphate and benzoyl peroxide from consumers worldwide. This will help expand the reach of these products in different regions across globe.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clindamycin Phosphate and Benzoyl Peroxide Market Research Report
By Type
1.2%/2.5%, 1.2%/3.75%, 1%/5%, 1%/3%
By Application
Hospital, Drug Sotre
By Companies
Bausch Health, Perrigo, Mylan, Tolmar, TARO, GSK, Bausch Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Clindamycin Phosphate and Benzoyl Peroxide Market Report Segments:
The global Clindamycin Phosphate and Benzoyl Peroxide market is segmented on the basis of:
Types
1.2%/2.5%, 1.2%/3.75%, 1%/5%, 1%/3%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Sotre
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- Perrigo
- Mylan
- Tolmar
- TARO
- GSK
- Bausch Health
Highlights of The Clindamycin Phosphate and Benzoyl Peroxide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1.2%/2.5%
- 1.2%/3.75%
- 1%/5%
- 1%/3%
- By Application:
- Hospital
- Drug Sotre
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clindamycin Phosphate and Benzoyl Peroxide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clindamycin phosphate is an antibiotic that is used to treat a variety of infections, including acne. Benzoyl peroxide is an antibacterial agent that helps to clear skin lesions and reduce the number of acne breakouts.
Some of the key players operating in the clindamycin phosphate and benzoyl peroxide market are Bausch Health, Perrigo, Mylan, Tolmar, TARO, GSK, Bausch Health.
The clindamycin phosphate and benzoyl peroxide market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clindamycin Phosphate and Benzoyl Peroxide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clindamycin Phosphate and Benzoyl Peroxide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clindamycin Phosphate and Benzoyl Peroxide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clindamycin Phosphate and Benzoyl Peroxide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clindamycin Phosphate and Benzoyl Peroxide Market Size & Forecast, 2020-2028
4.5.1 Clindamycin Phosphate and Benzoyl Peroxide Market Size and Y-o-Y Growth
4.5.2 Clindamycin Phosphate and Benzoyl Peroxide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1.2%/2.5%
5.2.2 1.2%/3.75%
5.2.3 1%/5%
5.2.4 1%/3%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Sotre
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clindamycin Phosphate and Benzoyl Peroxide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clindamycin Phosphate and Benzoyl Peroxide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1.2%/2.5%
9.6.2 1.2%/3.75%
9.6.3 1%/5%
9.6.4 1%/3%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Sotre
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1.2%/2.5%
10.6.2 1.2%/3.75%
10.6.3 1%/5%
10.6.4 1%/3%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Sotre
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1.2%/2.5%
11.6.2 1.2%/3.75%
11.6.3 1%/5%
11.6.4 1%/3%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Sotre
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1.2%/2.5%
12.6.2 1.2%/3.75%
12.6.3 1%/5%
12.6.4 1%/3%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Sotre
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1.2%/2.5%
13.6.2 1.2%/3.75%
13.6.3 1%/5%
13.6.4 1%/3%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Sotre
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clindamycin Phosphate and Benzoyl Peroxide Market: Competitive Dashboard
14.2 Global Clindamycin Phosphate and Benzoyl Peroxide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 Perrigo
14.3.3 Mylan
14.3.4 Tolmar
14.3.5 TARO
14.3.6 GSK
14.3.7 Bausch Health
